Questions About Cancer? 1-800-4-CANCER

Multiple Myeloma/Plasma Cell Neoplasms - Featured Clinical Trials

The following list shows Featured Clinical Trials for a specific type of cancer. You may also want to view:

  • Treating Patients with High-Risk Smoldering Myeloma
    (Posted: 12/11/2012) - In this phase III clinical trial, patients with smoldering myeloma classified as high risk for progression will be randomly assigned to undergo standard observation or six 4-week courses of treatment with the drug lenalidomide.
  • Preventing Graft-versus-Host Disease during Hematologic Cancer Treatment
    (Posted: 05/31/2005) - Researchers are investigating whether an immunosuppressive drug, sirolimus, can work with cyclosporine to prevent graft-versus-host disease (GVHD) more effectively than cyclosporine alone following allogeneic hematopoietic stem cell transplantation.